Porth Ymchwil

Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids: comment on the article by Gonzalez-Juanatey et al

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

StandardStandard

Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids: comment on the article by Gonzalez-Juanatey et al. / Sandoo, Aamer; Toms, Tracey; Zanten, Jet Veldhuijzen van et al.
Yn: Arthritis and Rheumatism, Cyfrol 61, Rhif 6, 15.06.2009, t. 854-5; author reply 855-6.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

HarvardHarvard

Sandoo, A, Toms, T, Zanten, JVV, Carroll, D & Kitas, G 2009, 'Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids: comment on the article by Gonzalez-Juanatey et al', Arthritis and Rheumatism, cyfrol. 61, rhif 6, tt. 854-5; author reply 855-6. https://doi.org/10.1002/art.24582

APA

Sandoo, A., Toms, T., Zanten, J. V. V., Carroll, D., & Kitas, G. (2009). Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids: comment on the article by Gonzalez-Juanatey et al. Arthritis and Rheumatism, 61(6), 854-5; author reply 855-6. https://doi.org/10.1002/art.24582

CBE

Sandoo A, Toms T, Zanten JVV, Carroll D, Kitas G. 2009. Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids: comment on the article by Gonzalez-Juanatey et al. Arthritis and Rheumatism. 61(6):854-5; author reply 855-6. https://doi.org/10.1002/art.24582

MLA

Sandoo, Aamer et al. "Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids: comment on the article by Gonzalez-Juanatey et al". Arthritis and Rheumatism. 2009, 61(6). 854-5; author reply 855-6. https://doi.org/10.1002/art.24582

VancouverVancouver

Sandoo A, Toms T, Zanten JVV, Carroll D, Kitas G. Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids: comment on the article by Gonzalez-Juanatey et al. Arthritis and Rheumatism. 2009 Meh 15;61(6):854-5; author reply 855-6. doi: 10.1002/art.24582

Author

Sandoo, Aamer ; Toms, Tracey ; Zanten, Jet Veldhuijzen van et al. / Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids : comment on the article by Gonzalez-Juanatey et al. Yn: Arthritis and Rheumatism. 2009 ; Cyfrol 61, Rhif 6. tt. 854-5; author reply 855-6.

RIS

TY - JOUR

T1 - Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids

T2 - comment on the article by Gonzalez-Juanatey et al

AU - Sandoo, Aamer

AU - Toms, Tracey

AU - Zanten, Jet Veldhuijzen van

AU - Carroll, Douglas

AU - Kitas, George

PY - 2009/6/15

Y1 - 2009/6/15

KW - Antibodies, Monoclonal

KW - Antibodies, Monoclonal, Murine-Derived

KW - Antirheumatic Agents

KW - Arthritis, Rheumatoid

KW - Blood Proteins

KW - Drug Therapy, Combination

KW - Glucocorticoids

KW - Humans

KW - Infusions, Intravenous

KW - Lipids

KW - Methylprednisolone

KW - Regional Blood Flow

KW - Rituximab

KW - Vasodilation

KW - Comment

KW - Letter

U2 - 10.1002/art.24582

DO - 10.1002/art.24582

M3 - Article

C2 - 19479694

VL - 61

SP - 854-5; author reply 855-6

JO - Arthritis and Rheumatism

JF - Arthritis and Rheumatism

SN - 0004-3591

IS - 6

ER -